Roche’s Hivid (ddC)
Executive Summary
NDA for the AIDS drug will be reviewed by Antiviral Drugs Advisory Committee April 20-21 ("The Pink Sheet" Jan. 27, T&G-7). Committee convenes at 8:30 a.m. April 20 and 7:30 a.m. on April 21 at the Bethesda Ramada Inn, 8400 Wisconsin Ave., Bethesda, Md.